| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| 2021 | 2022 | 2023 | Q'24 | |
|---|---|---|---|---|
| Cash | 5.67 | 4.08 | 3.49 | 6.70 |
| Receivables | 0.07 | 0.14 | 0.13 | 0.18 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 5.74 | 4.22 | 3.62 | 6.88 |
| 2021 | 2022 | 2023 | Q'24 | |
|---|---|---|---|---|
| Payables | 1.15 | 1.45 | 2.64 | 1.92 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 2.09 | 2.73 | 4.34 | 3.87 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡ | ‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Year |
|---|
| Year |
|---|
| Year |
|---|
| Year |
|---|
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 8.10 | 7.80 | — | — | — |
Low Price
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 14.87 | 12.66 | — | — | — |
High Price
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 4 | 4 | — | — | — |
Employees
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | — | — | — |
Revenue/Emp
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Gross Margin
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
EBT
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
EBT Margin
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | — | — | — |
Net Income
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Depreciation
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Earnings/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Capex/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Free CF/Sh
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | — | — | — |
Book Value/Sh
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Shares
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
PE Ratio
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
PS Ratio
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
PB Ratio
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
EV/Sales
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
EV/FCF
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Op' Cash Flow
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Capex
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
FCF
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.49 | (0.71) | — | — | — |
Working Cap'
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.76 | 10.98 | — | — | — |
Total Debt
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.68 | 7.49 | — | — | — |
Net Debt
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.37 | 30.72 | — | — | — |
Sh' Equity
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00% | 0.00% | — | — | — |
ROA
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00% | 0.00% | — | — | — |
ROIC
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
ROE
|
Gyrodyne, LLC (GYRO), a small-cap REIT specializing in Long Island industrial and office properties, exemplifies asset-heavy stagnation amid commercial real estate headwinds like post-2008 slowdowns, COVID-driven office vacancies, and 2022 interest rate hikes. Over the past decade, its stock has eroded 61-73% from 2016 highs, stabilizing near recent lows with no revenue, zero net income, and a skeletal staff of four employees since 2017—operating more as a wind-down holding company following a 2017 strategic review and key property sales.
Balance sheet strains underscore the distress: shareholder equity grew modestly to $30.7 million by 2023, but debt exploded 899% to $11 million, flipping net debt positive by $7.5 million and turning working capital negative at -$0.71 million. Zero profitability metrics (ROA/ROIC at 0%) and recent insider sells totaling $50,000—without any buys—signal eroding confidence, decoupling GYRO from thriving REIT peers amid illiquid assets and rising leverage risks.
With no analyst coverage or forward projections, the outlook points to a liquidation grind: modest NAV realization possible via asset sales, but mounting debt and operational void cap upside, potentially testing new lows if rates persist. Investors face a classic value trap demanding vigilance on refinancing or special dividends.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.